Abstract
Radiation recall pneumonitis (RRP) describes inflammatory reactions at previously irradiated fields of pulmonary tissue after exposure to certain systemic agents. Immune checkpoint inhibitors (ICIs) have been reported as potential causal agents of RRP in lung cancer. Yet, the general characteristics and risk factors of ICI-related RRP remain unclear. This study investigates the incidence, characteristics, and risk factors of RRP induced by ICIs after thoracic radiotherapy in patients with lung cancer.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
